Impact of alcohol on the histological and clinical progression of hepatitis C infection

Hepatology

Volumn 28, Issue 3, 1998, Pages 805-809

  Wiley, Thelma E ^a   Mccarthy, Mary ^a   Breidi, Lama ^a   Mccarthy, Monica ^a   Layden, Thomas J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FERRITIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031721879     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280330     Document Type: Article

References (19)

1. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
2. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpoler JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-974.
3. Takahashi M, Yamada G, Miyamato R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-243.
4. Seeff LB, Buskell-Bales Z, Wright EC, Durato SJ, Alter HJ, Iber FL, et al. Long term mortality after transfusion-associated nonA, nonB hepatitis. N Engl J Med 1992;27:1906-1911.
5. Tassopoulos NC. Patterns of progression: Unpredictability and risk of decompensated cirrhosis. Dig Dis Sci 1996;41(12):41S-48S.
6. Befrits R, Hedman M, Blomquist L, Allander T, Grillner L, Kinnman N, Rubio C, et al. Chronic hepatitis C in alcoholic patients: Prevalence, genotypes and correlation to liver disease. Scand J Gastroenterol 1995;30:1113-1118.
7. Coelho-Little ME, Jeffers LJ, Bernstein DE, Goodman JJ, Reddy KR, de Medina M, Li X, et al. Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease. Alcohol Clin Exp Res 1995; 19(5):1173-1176.
8. Caldwell SH, Li S, Rourk RM, Millar A, Sosnowski KM, Sue M, Barritt AS, et al. Hepatitis C infection by polymerase chain reaction in alcoholics: False-positive ELISA results and the influence of infection on a clinical prognostic score. Am J Gastroenterol 1993;88(7):1016-1021.
9. Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. HEPATOLOGY 1991;14:581-589.
10. Caldwell SH, Jeffers LJ, Ditomease A, Millar A, Clark RM, Rabassa A, Reddy KR, et al. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors. Am J Gastroenterol 1991;86:1219-1223.
11. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. HEPATOLOGY 1990;12: 1295-1299.
12. Nishiguchi S, Kuroki R, Yabusako T, Seki S, Kobayashi K, Monna T, Otani S, et al. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. HEPATOLOGY 1991;14: 985-989.
13. Bellentani S, Tiribelli C, Saccoccio G, Soddle M, Frutti N, DeMartin C, Christianni G, et al. Prevalence of chronic liver disease in the general population of Northern Italy. The Dionysos Study. HEPATOLOGY 1994;20: 1442-1449.
14. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahome Y, Sugai Y, Tanaka T, et al. Typing hepatitis C virus by polymerase chain reaction with type specific primers application to clinical surveys and tracing infection sources. J Gen Virol 1992;73(3):673-679.
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-439.
16. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-1695.
17. Pistello M, Maggi F, Vatteroni L, Ceccini N, Panicucci F, Bresci GP, Gambardella L, et al. Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol 1994;32:232-234.
18. Pozzato G, Moretti M, Crocé LS, Sasso F, Kaneko S, Unoura M, Kobayashi M, et al. Interferon therapy in chronic hepatitis C virus: evidence of different outcome with respect to viral strains. J Med Virol 1995;45:445-450.
19. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21:285-290.